Author:
Ghosh Supurna,Wu Yi,Stack M. Sharon
Reference103 articles.
1. Afzal, S., Lalani el, N., Foulkes, W. D., Boyce, B., Tickle, S., Cardillo, M. R., Baker, T., Pignatelli, M., and Stamp, G. W. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Lab Invest 1996; 74: 406–21.
2. Afzal, S., Lalani, E. N., Poulsom, R., Stubbs, A., Rowlinson, G., Sato, H., Seiki, M., and Stamp, G. W. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998; 29: 155–65.
3. Andreasen, P. A., Kjoller, L., Christensen, L., and Duffy, M. J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997; 72: 1–22.
4. Astedt, B., Svanberg, L., and Nilsson, I. M. Fibrin degradation products and ovarian tumours. Br Med J 1971; 4: 458–9.
5. Band, V., Karlan, B. Y., Zurawski, V. R., Jr., and Littlefield, B. A. Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells. J Cell Physiol 1989; 138: 106–14.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献